These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11647660)

  • 61. 3-year inquiry exonerates breast cancer researcher.
    Weiss R
    Washington Post; 1997 Mar; ():A13. PubMed ID: 11647160
    [No Abstract]   [Full Text] [Related]  

  • 62. Risky alliance on medicine's cutting edge: firm faces business, ethics issues in NIH joint venture.
    Lehrman S
    Washington Post; 1991 Aug; ():Business 1, 14. PubMed ID: 11646923
    [No Abstract]   [Full Text] [Related]  

  • 63. Profits and ethics clash in research on genetic coding.
    Fisher LM
    N Y Times Web; 1994 Jan; ():1, 18. PubMed ID: 11647947
    [No Abstract]   [Full Text] [Related]  

  • 64. United States: protecting the integrity of research.
    Sibbison JB
    Lancet; 1989 Nov; 2(8671):1094. PubMed ID: 11644437
    [No Abstract]   [Full Text] [Related]  

  • 65. Scientist ousted from cancer study declines to testify to House panel.
    Altman LK
    N Y Times Web; 1994 Apr; ():C1, C3. PubMed ID: 11647971
    [No Abstract]   [Full Text] [Related]  

  • 66. Drug firm was aware of deaths, probe says.
    Mintz M
    Washington Post; 1982 Dec; ():A2. PubMed ID: 11647760
    [No Abstract]   [Full Text] [Related]  

  • 67. Teaching scientific integrity.
    Gifford F
    Centen Rev; 1994; 38(2):297-314. PubMed ID: 11656760
    [No Abstract]   [Full Text] [Related]  

  • 68. U.S. limits doctors in their referrals.
    Pear R
    N Y Times Web; 1991 Jul; ():A1, A15. PubMed ID: 11646906
    [No Abstract]   [Full Text] [Related]  

  • 69. Tangled lifeline.
    Cohen S
    Washington Post; 1996 Aug; ():10-15, 26-32. PubMed ID: 11647686
    [No Abstract]   [Full Text] [Related]  

  • 70. What market values are doing to medicine.
    Relman AS
    Atlantic; 1992 Mar; 269(3):98-102, 105-106. PubMed ID: 11651349
    [No Abstract]   [Full Text] [Related]  

  • 71. If it's research, it must be reviewed: an NIH reprimand.
    Levine C
    Hastings Cent Rep; 1986 Feb; 16(1):2-3. PubMed ID: 11643913
    [No Abstract]   [Full Text] [Related]  

  • 72. The role and responsibility of industry in research.
    Lasagna L
    Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
    [No Abstract]   [Full Text] [Related]  

  • 73. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
    Schuchardt EJ
    Columbia J Law Soc Probl; 1992; 26(1):77-115. PubMed ID: 11651647
    [No Abstract]   [Full Text] [Related]  

  • 74. Probe into flawed cancer study.
    Altman LK
    N Y Times Web; 1994 Apr; ():C3. PubMed ID: 11647029
    [No Abstract]   [Full Text] [Related]  

  • 75. Proposal to test drugs in children meets resistance.
    Pear R
    N Y Times Web; 1997 Nov; ():1, 28. PubMed ID: 11647286
    [No Abstract]   [Full Text] [Related]  

  • 76. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information.
    Samuels A
    Account Res; 1999; 6(4):259-310. PubMed ID: 11657840
    [No Abstract]   [Full Text] [Related]  

  • 77. Playing roulette with experimental drugs.
    Budiansky S
    US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
    [No Abstract]   [Full Text] [Related]  

  • 78. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
    Annas GJ
    Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
    [No Abstract]   [Full Text] [Related]  

  • 79. The fraud case that evaporated.
    N Y Times Web; 1996 Jun; ():A20. PubMed ID: 11647106
    [No Abstract]   [Full Text] [Related]  

  • 80. Researchers must inform subjects about financial incentives for study.
    Maloney DM
    Hum Res Rep; 1999 Aug; 14(8):6. PubMed ID: 11657806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.